Narodny Ustav Detskych Chorob
- Address
- lock Available on a paid plan
Bacterial Infections and Mycoses
The site investigates treatments for serious bacterial and fungal infections in children, aiming to improve safety and effectiveness.
- Complicated urinary tract infections
- Acute bacterial sepsis
- Hospital‑acquired fungal infections
Research includes evaluating new antimicrobial agents and optimizing dosing strategies to reduce infection‑related complications.
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Studies focus on rare inherited disorders that affect infants and children, seeking better therapeutic options.
- Osteogenesis Imperfecta
- Primary Immunodeficiency Diseases
- Genetic metabolic syndromes
Trials assess gene‑targeted therapies and immune‑supportive products to enhance growth and immune function.
Eye Diseases
Pediatric eye health is addressed through trials that aim to slow disease progression and improve visual outcomes.
- Myopia progression
- Pediatric uveitis
- Congenital cataract
The research evaluates novel ophthalmic solutions and device‑based interventions to preserve vision.
Hemic and Lymphatic Diseases
The clinic conducts extensive research on blood‑related cancers, testing innovative therapies to increase survival rates.
- Acute Lymphoblastic Leukaemia
- Lymphoblastic lymphoma
- Anaplastic Large Cell Lymphoma
- Neuroblastoma
- Rhabdomyosarcoma
- Ewing sarcoma
Efforts include immunotherapy, targeted agents, and stem‑cell transplantation to improve long‑term remission.
Immune System Diseases
Trials target disorders of immune regulation, aiming to restore balance and reduce disease activity.
- Multiple Sclerosis
- Atopic Dermatitis
- Primary Immunodeficiency Diseases
Studies compare novel biologics with existing standards to determine superior efficacy and safety.
Musculoskeletal Diseases
Research seeks to strengthen bone health and reduce fracture risk in children with skeletal fragility.
- Osteogenesis Imperfecta
- Juvenile idiopathic arthritis
- Muscular dystrophy
Investigations include bone‑forming agents and rehabilitation protocols to enhance mobility.
Neoplasms
A broad portfolio of cancer trials evaluates cutting‑edge treatments across solid and hematologic tumors in young patients.
- Hepatoblastoma
- High‑risk neuroblastoma
- Relapsed acute lymphoblastic leukemia
- Metastatic sarcomas
The program emphasizes personalized medicine, combining targeted drugs with conventional chemotherapy.
Nervous System Diseases
Neurological conditions are studied to improve function and quality of life for affected children.
- Multiple Sclerosis
- Chronic Migraine
- Neurogenic Detrusor Overactivity
Trials test neuromodulators and disease‑modifying therapies to reduce symptom burden.
Nutritional and Metabolic Diseases
Metabolic health research addresses obesity and related disorders to promote healthier growth trajectories.
- Obesity
- Type 2 Diabetes
- Metabolic syndrome
Interventions include lifestyle programs and novel metabolic agents aimed at weight management.
Pathological Conditions, Signs and Symptoms
Studies focus on common pediatric symptoms to develop better diagnostic tools and symptom‑relief strategies.
- Atopic Dermatitis
- Chronic Migraine
- Painful urination
The work integrates patient‑reported outcomes to tailor therapies to individual needs.
Skin and Connective Tissue Diseases
Dermatologic trials aim to control inflammation and prevent long‑term skin damage in children.
- Atopic Dermatitis
- Pediatric psoriasis
- Connective tissue disorders
Innovative topical agents and systemic treatments are evaluated for safety and rapid symptom control.
Virus Diseases
Viral infection research, especially COVID‑19, seeks effective treatments for immunocompromised children.
- COVID‑19
- Pediatric influenza
- Viral gastroenteritis
Studies assess antiviral combinations and immune‑boosting strategies to reduce severe outcomes.
Immune System Processes
Fundamental investigations explore how the immune system functions in health and disease, guiding future therapeutic design.
- Immune cell signaling
- Complement pathway regulation
- Cytokine storm mitigation
Findings support the development of next‑generation immunomodulators for pediatric use.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 2 of 14 therapeutic areas and 15 of 93 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 85 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 18 by active trials.
- 1Pfizer Inc.2active
lock +17 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Pfizer Inc.4trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Narodny Ustav Detskych Chorob
lock Showing 1 of 32 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3, Open-label, Uncontrolled Study to Evaluate the Activity, Safety, Pharmacokinetics and Pharmacodynamics of Roxadustat for the Treatment of Anemia in Pediatric Participants with Chronic Kidney Disease | Astellas Pharma Global Development Inc. | Phase III | Recruiting | Dec 2023 | — |
IMP list
lock Showing 1 of 93 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Etoposide | 5 | Unknown | 2014-03-27 | 2024-11-21 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.